Eton Pharmaceuticals (ETON) Cash & Equivalents Growth (1y) (2018 - 2026)
Eton Pharmaceuticals (ETON) Cash & Equivalents Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 69.13% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 2.86% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 19.56% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 13.19% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 56.51% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 25.91% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -1.67% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | -4.65% |
| 10 | Eton Pharmaceuticals | 1.76 Bn | 1.73 Bn | 25.41 Mn | 5.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.78% |
| Dec 31, 2025 | 73.69% |
| Sep 30, 2025 | 83.21% |
| Jun 30, 2025 | 43.43% |
| Mar 31, 2025 | 4.59% |
| Dec 31, 2024 | -30.17% |
| Sep 30, 2024 | -8.20% |
| Jun 30, 2024 | -17.95% |
| Mar 31, 2024 | 13.24% |
| Dec 31, 2023 | 31.17% |
| Sep 30, 2023 | 64.97% |
| Jun 30, 2023 | 26.52% |
| Mar 31, 2023 | -3.42% |
| Dec 31, 2022 | 13.18% |
| Sep 30, 2022 | -41.09% |
| Jun 30, 2022 | -33.94% |
| Mar 31, 2022 | -39.36% |
| Dec 31, 2021 | -32.35% |
| Sep 30, 2021 | 209.72% |
| Jun 30, 2021 | 151.24% |